| Subject: | FDA Issues Class I Recall of ProbeTec ET Urine Processing Kit |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Mon, 14 Feb 2005 - 10:00 am |
| The FDA in conjunction with Becton Dickinson alerted healthcare professionals of the recall (Class I recall) of Becton Dickinson's ProbeTec ET Urine Processing Kit due to the possibility of indeterminate and false negative clinical results when testing for Chlamydia and gonorrhea. The Urine Processing Kit is designed to remove amplification inhibitors for testing urine specimens with Chlamydia trachomatis and Neisseria gonorrhoeae amplified DNA assays. These two organisms are common causes of... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
Related MCN Products:
|
|
StayAlert! provides immediate notification of regulatory body legislation impacting the healthcare industry, helping you to meet regulatory compliance. Subscribers are notified of any new or revised regulations, provided with a summary of the regulation, followed by an implementation action plan and/or policy. Designed as an e-mail "push" method for rapid customer notification of healthcare compliance issues, paired with interpretative analysis and practical application, the StayAlert!® Virtual Compliance Administrator™ saves you time and money. StayAlert! is the only comprehensive clinical and regulatory service providing organizations in the healthcare arena with practical applications to meet complex mandated federal requirements. |
|
